Advisor Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $6.28M | Buy |
81,587
+7,055
| +9% | +$537K | 0.44% | 40 |
|
|
2022
Q1 | $5.44M | Buy |
74,532
+1,528
| +2% | +$103K | 0.34% | 51 |
|
|
2021
Q4 | $4.55M | Sell |
73,004
-4,693
| -6% | -$275K | 0.27% | 62 |
|
|
2021
Q3 | $4.6M | Sell |
77,697
-3,535
| -4% | -$233K | 0.31% | 60 |
|
|
2021
Q2 | $5.43M | Sell |
81,232
-1,081
| -1% | -$70.5K | 0.36% | 55 |
|
|
2021
Q1 | $5.2M | Sell |
82,313
-4,212
| -5% | -$262K | 0.37% | 53 |
|
|
2020
Q4 | $5.37M | Buy |
86,525
+2,189
| +3% | +$135K | 0.4% | 49 |
|
|
2020
Q3 | $5.08M | Buy |
84,336
+1,205
| +1% | +$72.5K | 0.44% | 48 |
|
|
2020
Q2 | $4.89M | Buy |
83,131
+3,295
| +4% | +$197K | 0.46% | 48 |
|
|
2020
Q1 | $4.45M | Buy |
79,836
+9,454
| +13% | +$578K | 0.54% | 41 |
|
|
2019
Q4 | $4.69M | Buy |
70,382
+32,507
| +86% | +$1.86M | 0.48% | 47 |
|
|
2019
Q3 | $1.92M | Buy |
37,875
+9,016
| +31% | +$424K | 0.23% | 86 |
|
|
2019
Q2 | $1.31M | Sell |
28,859
-3,654
| -11% | -$170K | 0.16% | 121 |
|
|
2019
Q1 | $1.55M | Sell |
32,513
-7,436
| -19% | -$370K | 0.2% | 98 |
|
|
2018
Q4 | $2.08M | Buy |
39,949
+2,164
| +6% | +$116K | 0.33% | 66 |
|
|
2018
Q3 | $2.35M | Buy |
37,785
+3,541
| +10% | +$210K | 0.32% | 62 |
|
|
2018
Q2 | $1.9M | Sell |
34,244
-7,826
| -19% | -$423K | 0.32% | 65 |
|
|
2018
Q1 | $2.66M | Buy |
42,070
+921
| +2% | +$59.2K | 0.49% | 45 |
|
|
2017
Q4 | $2.56M | Buy |
41,149
+4,188
| +11% | +$262K | 0.46% | 44 |
|
|
2017
Q3 | $2.36M | Buy |
36,961
+2,382
| +7% | +$139K | 0.46% | 43 |
|
|
2017
Q2 | $1.93M | Buy |
34,579
+1,891
| +6% | +$103K | 0.45% | 45 |
|
|
2017
Q1 | $1.78M | Buy |
32,688
+1,190
| +4% | +$65.3K | 0.47% | 43 |
|
|
2016
Q4 | $1.84M | Buy |
31,498
+7,689
| +32% | +$420K | 0.55% | 38 |
|
|
2016
Q3 | $1.28M | Sell |
23,809
-9,784
| -29% | -$628K | 0.43% | 57 |
|
|
2016
Q2 | $2.47M | Buy |
33,593
+1,701
| +5% | +$120K | 0.86% | 25 |
|
|
2016
Q1 | $2.04M | Sell |
31,892
-7,768
| -20% | -$490K | 0.76% | 34 |
|
|
2015
Q4 | $2.73M | Buy |
39,660
+7,846
| +25% | +$518K | 0.93% | 24 |
|
|
2015
Q3 | $1.88M | Sell |
31,814
-2,495
| -7% | -$158K | 0.79% | 33 |
|
|
2015
Q2 | $2.23M | Buy |
34,309
+2,729
| +9% | +$180K | 0.86% | 24 |
|
|
2015
Q1 | $2.04M | Sell |
31,580
-9
| -0% | -$563 | 0.86% | 22 |
|
|
2014
Q4 | $1.86M | Buy |
31,589
+760
| +2% | +$42.9K | 0.82% | 28 |
|
|
2014
Q3 | $1.58M | Buy |
30,829
+1,708
| +6% | +$85.3K | 0.9% | 30 |
|
|
2014
Q2 | $1.41M | Buy |
29,121
+281
| +1% | +$13.8K | 0.7% | 38 |
|
|
2014
Q1 | $1.5M | Sell |
28,840
-706
| -2% | -$37.6K | 0.82% | 30 |
|
|
2013
Q4 | $1.57M | Buy |
29,546
+2,980
| +11% | +$152K | 0.9% | 25 |
|
|
2013
Q3 | $1.23M | Sell |
26,566
-817
| -3% | -$35.9K | 0.88% | 29 |
|
|
2013
Q2 | $1.22M | Buy |
+27,383
| New | +$1.19M | 1% | 22 |
|
Other funds holding BMY
Advisor Partners's BMY Position: Q2 2022 in Review
Advisor Partners increased its Bristol-Myers Squibb (BMY) stake by 9.5% in Q2 2022, buying an estimated $537K and bringing the position to 81,587 shares worth $6.28M. The position accounts for 0.44% of the portfolio, ranked #40.
Advisor Partners first reported a position in BMY in Q2 2013 and has held it in 37 quarters since. 2,538 funds tracked by Wall St. Rank hold BMY as of Q2 2022.
- Advisor Partners held 81,587 shares of Bristol-Myers Squibb worth $6.28M as of Q2 2022.
- Advisor Partners bought 7,055 Bristol-Myers Squibb shares in Q2 2022, an estimated $537K.
- Bristol-Myers Squibb made up 0.44% of Advisor Partners's portfolio in Q2 2022, its #40 holding.
- Advisor Partners first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 37 quarters since.
- 2,538 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.
Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.